Sangamo Therapeutics SGMO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.42 | 100.61 | -0.11 | -38,203 | -37 | |
| 2025Q3 | 0.67 | 101.32 | -0.11 | -35,553 | -35 | |
| 2025Q2 | 0.54 | 89.46 | -0.08 | -17,855 | -20 | |
| 2025Q1 | 0.66 | 97.21 | -0.14 | -29,628 | -31 | |
| 2024Q4 | 1.02 | 109.10 | -0.12 | -25,990 | -23 | |
| 2024Q3 | 0.87 | 98.80 | 0.07 | 10,631 | 11 | |
| 2024Q2 | 0.36 | 102.86 | -0.17 | -37,084 | -36 | |
| 2024Q1 | 0.67 | 105.17 | -0.27 | -51,526 | -49 | |
| 2023Q4 | 0.54 | 102.46 | -0.34 | -62,059 | -60 | |
| 2023Q3 | 0.60 | 103.42 | -0.60 | -106,408 | -104 | |
| 2023Q2 | 1.30 | 102.32 | -0.66 | -123,572 | -115 | |
| 2023Q1 | 1.76 | 84.56 | 0.12 | 18,034 | 21 | |
| 2022Q4 | 3.14 | 107.11 | -0.32 | -55,392 | -52 | |
| 2022Q3 | 4.90 | 103.33 | -0.34 | -54,894 | -53 | |
| 2022Q2 | 4.14 | 106.13 | -0.29 | -45,734 | -43 | |
| 2022Q1 | 5.81 | 103.06 | -0.30 | -45,261 | -44 | |
| 2021Q4 | 7.50 | 106.22 | -0.25 | -39,899 | -37 | |
| 2021Q3 | 9.01 | 101.75 | -0.33 | -48,436 | -48 | |
| 2021Q2 | 11.97 | 103.29 | -0.33 | -48,700 | -47 | |
| 2021Q1 | 12.53 | 101.37 | -0.32 | -46,302 | -46 |